Staurosporine, renowned for its prowess as a kinase inhibitor, casts a wide net, potentially curtailing the activity of a vast array of kinases. This broad-spectrum action places it as a prime candidate for influencing LOC728241, assuming it's part of the kinase ensemble. Rapamycin, on the other hand, is a specialist in immunosuppression that targets mTOR by forming a complex with FKBP12. If LOC728241 is intertwined with the mTOR pathway, rapamycin could significantly alter its operational landscape. LY294002, with its selective inhibition of PI3K, serves to dampen Akt signaling pathways, which, if associated with LOC728241's functionality, might suppress its activity. Similarly, PD98059 takes aim at MEK to block the MAPK/ERK pathway, potentially reshaping LOC728241's role if it's a component of this signaling cascade. U0126, another MEK adversary, also impedes MAPK/ERK activation, hinting at a possible pivot in LOC728241's function contingent on this pathway.
SB203580 targets p38 MAPK and could modify LOC728241 activity if it is reactive to cellular stress signals, while SP600125, a JNK inhibitor, may influence LOC728241 if JNK signaling forms part of its regulatory network. Bortezomib throws a wrench into the proteasomal machinery, disrupting protein degradation. If LOC728241's stability is maintained by ubiquitination, its levels could be bolstered by this intervention. Delving into protein stabilization, 17-AAG (Tanespimycin) challenges Hsp90, which might impact LOC728241 if it relies on Hsp90's chaperoning for its stability or function. Thapsigargin, a disruptor of calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, could affect LOC728241 if it is calcium-dependent, altering its functional repertoire. Cyclopamine puts the brakes on the Hedgehog pathway, potentially altering LOC728241 activity if the protein is an actor within this signaling troupe. Lastly, Imatinib, by targeting specific tyrosine kinases such as BCR-ABL, c-Kit, and PDGFR, might alter the phosphorylation status and consequently the activity of LOC728241, should it be influenced by these kinases.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can inhibit a broad range of kinases, potentially affecting LOC728241 if it is kinase-associated. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that can alter cell signaling, potentially affecting LOC728241 if part of this pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can disrupt protein degradation pathways, potentially affecting LOC728241 if it is degradation-linked. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An ER stress inducer that inhibits the Ca2+ ATPase, potentially affecting LOC728241 if it is involved in calcium homeostasis. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A MEK inhibitor that can inhibit the MAPK/ERK pathway, potentially affecting LOC728241 if it interacts with this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can suppress the AKT pathway, potentially affecting LOC728241 if it is associated with this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MAPK inhibitor that can prevent the activation of MAPK/ERK, potentially affecting LOC728241 if it is part of this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can alter cell growth and survival signals, potentially affecting LOC728241 if involved in these processes. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
A tyrosine kinase inhibitor that can inhibit BCR-ABL and other kinases, potentially affecting LOC728241 if it is kinase-related. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
An Hsp90 inhibitor that can disrupt client protein stabilization, potentially affecting LOC728241 if it is an Hsp90 client. |